About Krka

Among the leaders

Krka is one of the top generic pharmaceutical companies in Europe. Its high quality, effective and safe products cover most therapeutic areas and we complete successfully with against other companies in our sector.
For half of the century we are successfully realising our strategic goals and doing that, follow our Mission and Vision.

Activities

Our core business operations involve pharmaceuticals and chemicals. We at Krka focus mainly on developing our own high quality generic medicines with added value, which we market under our own brand names. Our core products are those for human use and include prescription pharmaceuticals, self-medication products and cosmetic products. We also manufacture and market animal health products. Our range of operation is further complemented by health resort and tourist services of our daughter company Terme Krka .

More

Markets

Krka is a recognised innovative generic company. Our products are sold in more then 70 countries worldwide. Our traditional markets extend from Vladivostok to Lisbon. Our international presence is strengthened by numerous companies and representative offices abroad and through our own production and distribution centres in Poland, the Russian Federation, Croatia and Germany.

More

Development

At Krka, we are intensively developing generic medicines with added value, which are the result of our own knowledge and know-how. By developing new medicines, we are constantly extending the Krka product range and are entering new therapeutic areas. Our products are marketed under our own brands.

More

Generics medicines

Generic medicines are the exact equivalent of original medicines whose patent protection has expired. They contain the same active pharmaceutical ingredients as the originals, and are equivalent in quality, efficacy and safety.

More

Quality

We realise that Krka's compatibility, productivity and good business results are based on the quality of our products. Production is in compliance with international production and pharmaceutical standards, as well as quality management standards, environmental system management standards, food safety principles, and health and safety at work principles.

More

Investments

Our strategic orientation towards developing Krka’s own generic medicines is also being realised through investment in research and development capacities (Notol, RKC II, Sinteza 4) and our own network of production-distribution centres covering several countries (Poland, Russian Federation, Croatia, Germany).

More

Environmental issues

Care for health and concern for quality of life is also reflected in our relationship with the environment. By developing high quality processes we are speeding up development of clean production, and reducing the burden on nature as much as we can. We are committed to balanced development, so we devote special attention to protecting health of our employees and the environment.

More

Careers development

A successful market presence, the development and marketing of new products, and investment in modern production capacity require a highly trained staff. Our knowledge and skills are developed and built on through education and training at home and abroad, and we also work hard at team work and positive interpersonal relations, which we also develop via activities in our free time.

We are creating a working environment that promotes employees’ professional and personal development, while we also carefully plan the influx of new staff by offering scholarships and encouraging innovation among young people, for example, via the well established Krka Awards.

More

Corporate citizenship/Sponsorship

At Krka, our basic commitment is to provide healthy and quality life to people in the medical and humanitarian domains, and invest in the development of sport, education, science and culture.

More